News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
174,085 Results
Type
Article (9432)
Company Profile (33)
Press Release (164620)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (51996)
Career Advice (265)
Deals (8201)
Drug Delivery (10)
Drug Development (13229)
Employer Resources (20)
FDA (4803)
Job Trends (4006)
News (81006)
Policy (7778)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
Academia (893)
Academic (1)
Allergies (20)
Alliances (16923)
ALS (10)
Alzheimer's disease (410)
Antibody-drug conjugate (ADC) (22)
Approvals (4852)
Artificial intelligence (105)
Autoimmune disease (1)
Automation (9)
Bankruptcy (61)
Best Places to Work (3131)
BIOSECURE Act (2)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (21)
Brain cancer (9)
Breast cancer (92)
Cancer (651)
Cardiovascular disease (43)
Career advice (242)
Career pathing (2)
CAR-T (25)
Cell therapy (62)
Cervical cancer (11)
Clinical research (10340)
Collaboration (267)
Compensation (17)
Complete response letters (3)
COVID-19 (818)
CRISPR (5)
C-suite (51)
Cystic fibrosis (15)
Data (484)
Decentralized trials (1)
Depression (7)
Diabetes (33)
Diagnostics (6096)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (29)
Drug pricing (4)
Drug shortages (2)
Duchenne muscular dystrophy (13)
Earnings (16118)
Employer branding (5)
Employer resources (18)
Events (20177)
Executive appointments (181)
FDA (5094)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (182)
Gene editing (9)
Generative AI (10)
Gene therapy (45)
GLP-1 (124)
Government (1234)
Grass and pollen (3)
Guidances (10)
Healthcare (4270)
IgA nephropathy (1)
Immunology and inflammation (9)
Indications (6)
Infectious disease (861)
Inflammatory bowel disease (18)
Influenza (18)
Intellectual property (17)
Interviews (30)
IPO (2721)
IRA (1)
Job creations (1005)
Job search strategy (231)
Kidney cancer (6)
Labor market (2)
Layoffs (48)
Leadership (2)
Legal (1482)
Liver cancer (15)
Lung cancer (91)
Lymphoma (48)
Machine learning (2)
Management (5)
Manufacturing (81)
MASH (8)
Medical device (3063)
Medtech (3063)
Mergers & acquisitions (5602)
Metabolic disorders (70)
Multiple sclerosis (23)
NASH (4)
Neurodegenerative disease (19)
Neuropsychiatric disorders (2)
Neuroscience (497)
NextGen: Class of 2025 (1249)
Non-profit (953)
Northern California (514)
Now hiring (11)
Obesity (30)
Opinion (22)
Ovarian cancer (15)
Pain (9)
Pancreatic cancer (13)
Parkinson's disease (26)
Partnered (7)
Patents (36)
Patient recruitment (15)
Peanut (12)
People (15500)
Pharmaceutical (7)
Phase I (3076)
Phase II (4086)
Phase III (3937)
Pipeline (234)
Policy (6)
Postmarket research (530)
Preclinical (1660)
Press Release (23)
Prostate cancer (47)
Psychedelics (3)
Radiopharmaceuticals (132)
Rare diseases (57)
Real estate (2422)
Recruiting (8)
Regulatory (5555)
Reports (13)
Research institute (896)
Resumes & cover letters (30)
Rett syndrome (1)
RSV (4)
Schizophrenia (1)
Series A (25)
Series B (16)
Service/supplier (2)
Sickle cell disease (5)
Southern California (432)
Spinal muscular atrophy (42)
Sponsored (9)
Startups (1063)
State (1)
Stomach cancer (4)
Supply chain (14)
Tariffs (1)
The Weekly (3)
United States (4845)
Vaccines (89)
Venture capitalists (7)
Weight loss (15)
Women's health (8)
Date
Today (37)
Last 7 days (172)
Last 30 days (529)
Last 365 days (7381)
2025 (2312)
2024 (7865)
2023 (9311)
2022 (14812)
2021 (14982)
2020 (14211)
2019 (10211)
2018 (7944)
2017 (8715)
2016 (8825)
2015 (9902)
2014 (7950)
2013 (7076)
2012 (7429)
2011 (7658)
2010 (6836)
Location
Africa (209)
Alabama (11)
Alaska (2)
Arizona (72)
Arkansas (4)
Asia (10148)
Australia (1989)
California (1152)
Canada (437)
China (60)
Colorado (75)
Connecticut (78)
Delaware (29)
Europe (24071)
Florida (148)
Georgia (46)
Idaho (8)
Illinois (123)
India (7)
Indiana (67)
Iowa (4)
Japan (41)
Kansas (27)
Kentucky (6)
Louisiana (2)
Maine (25)
Maryland (164)
Massachusetts (667)
Michigan (116)
Minnesota (89)
Missouri (48)
Montana (12)
Nebraska (8)
Nevada (4)
New Hampshire (19)
New Jersey (372)
New Mexico (19)
New York (467)
North Carolina (264)
North Dakota (6)
Northern California (514)
Ohio (60)
Oklahoma (4)
Oregon (7)
Pennsylvania (158)
Rhode Island (12)
South America (271)
South Carolina (7)
Southern California (432)
Tennessee (46)
Texas (250)
Utah (94)
Virginia (44)
Washington D.C. (10)
Washington State (128)
Wisconsin (30)
174,085 Results for "cdx laboratories cdx diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
April 1, 2025
·
8 min read
Press Releases
Tempus Announces the National Launch of FDA-Approved xT CDx Test
January 15, 2025
·
5 min read
Press Releases
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
February 26, 2025
·
7 min read
Press Releases
Celldex Therapeutics Presents Positive Preclinical Data from Inflammatory Bispecific Antibody Program CDX-622 at AAAAI 2025
March 3, 2025
·
5 min read
Press Releases
U.S. Food and Drug Administration Approves FoundationOne®CDx as a Companion Diagnostic for OJEMDA™ (tovorafenib) to Treat the Most Common Form of Childhood Brain Tumor in Pediatric Patients
January 17, 2025
·
5 min read
Press Releases
Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
December 29, 2024
·
6 min read
FDA
U.S. Food and Drug Administration (FDA) Approves FoundationOne®Liquid CDx as a Companion Diagnostic for AKEEGA® (niraparib and abiraterone acetate) for Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer
Foundation Medicine, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®Liquid CDx to be used as a companion diagnostic for AKEEGA® (niraparib and abiraterone acetate) from Janssen Biotech, Inc.
July 1, 2024
·
6 min read
Press Releases
Caris Life Sciences Receives FDA Approval for MI Cancer Seek™ as a Companion Diagnostic (CDx) Test
November 6, 2024
·
5 min read
Biotech Bay
Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced certification for its Guardant360® CDx blood test under the European Union’s In Vitro Diagnostic Regulation (IVDR 2017/746).
May 21, 2024
·
8 min read
Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
Telix Pharmaceuticals Limited announces that it has completed the submission of a Biologics License Application to the United States Food and Drug Administration for its investigational radiodiagnostic PET1 agent, TLX250-CDx, for the characterisation of renal masses as clear cell renal cell carcinoma.
June 2, 2024
·
7 min read
1 of 17,409
Next
